Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents

Cancer Research

Volumn 71, Issue 6, 2011, Pages 2240-2249

  Liu, Xiaoli ^a   Madhankumar, A B ^a   Slagle Webb, Becky ^a   Sheehan, Jonas M ^a   Surguladze, Nodar ^b   Connor, James R ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b Institute of Molecular Biology and Biological Physics   (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CASPASE 3; FERRITIN; LIPOSOME; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DNA SUPERCOILING; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE SILENCING; GLIOMA; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOFERRITINS; APOPTOSIS; BLOTTING, WESTERN; CARMUSTINE; CASPASE 3; CATIONS; CELL LINE, TUMOR; DNA, NEOPLASM; DNA, SUPERHELICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; GLIOMA; HUMANS; LIPOSOMES; MICE; MICE, NUDE; NUCLEIC ACID CONFORMATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952759169     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1375     Document Type: Article

References (33)

1. Skalski V, Rivas J, Panasci L, McQuillan A, Feindel W. The cytotoxicity of sarcosinamide chloroethylnitrosourea (SarCNU) and BCNU in primary gliomas and glioma cell lines: analysis of data in reference to theoretical peak plasma concentrations in man. Cancer Chemother Pharmacol 1988;22:137-40.
2. Gwak HS, Yoo HJ, Youn SM, Lee DH, Kim MS, Rhee CH. Radiosurgery for recurrent brain metastases after whole-brain radiotherapy: factors affecting radiation-induced neurological dysfunction. J Korean Neurosurg Soc 2009;45:275-83.
3. Takeshita F, Ochiya T. Therapeutic potential of RNA interference against cancer. Cancer Sci 2006;97:689-96. (Pubitemid 43983779)
4. Harrison PM, Treffry A, Lilley TH. Ferritin as an iron-storage protein: mechanisms of iron uptake. J Inorg Biochem 1986;27:287-93. (Pubitemid 17192385)
5. Carrondo MA. Ferritins, iron uptake and storage from the bacterioferritin viewpoint. EMBO J 2003;22:1959-68. (Pubitemid 36565522)
6. Surguladze N, Patton S, Cozzi A, Fried MG, Connor JR. Characterization of nuclear ferritin and mechanism of translocation. Biochem J 2005;388:731-40. (Pubitemid 40941558)
7. Outten FW, Theil EC. Iron-based redox switches in biology. Antioxid Redox Signal 2009;11:1029-46.
8. Pilon M, Cohu CM, Ravet K, Abdel-Ghany SE, Gaymard F. Essential transition metal homeostasis in plants. Curr Opin Plant Biol 2009;12:347-57.
9. Thompson KJ, Fried MG, Ye Z, Boyer P, Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci 2002;115:2165-77. (Pubitemid 34746382)
10. Surguladze N, Thompson KM, Beard JL, Connor JR, Fried MG. Interactions and reactions of ferritin with DNA. J Biol Chem 2004;279:14694-702. (Pubitemid 38618859)
11. Cai CX, Birk DE, Linsenmayer TF. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol Biol Cell 1998;9:1037-51. (Pubitemid 28457298)
12. Linsenmayer TF, Cai CX, Millholland JM, Beazley KE, Fitch JM. Nuclear ferritin in corneal epithelial cells: tissue-specific nuclear transport and protection from UV-damage. Prog Retin Eye Res 2005;24:139-59. (Pubitemid 40018222)
13. Cai C, Ching A, Lagace C, Linsenmayer T. Nuclear ferritin-mediated protection of corneal epithelial cells from oxidative damage to DNA. Dev Dyn 2008;237:2676-83.
14. McClarty GA, Chan AK, Choy BK, Wright JA. Increased ferritin gene expression is associated with increased ribonucleotide reductase gene expression and the establishment of hydroxyurea resistance in mammalian cells. J Biol Chem 1990;265:7539-47.
15. Güner G, Kirkali G, Yenisey C, Töre IR. Cytosol and serum ferritin in breast carcinoma. Cancer Lett 1992;67:103-12. (Pubitemid 23054876)
16. Kukulj S, Jaganjac M, Boranic M, Krizanac S, Santic Z, Poljak-Blazi M. Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer. Med Oncol 2010;27:268-77.
17. Pountney D, Trugnan G, Bourgeois M, Beaumont C. The identification of ferritin in the nucleus of K562 cells, and investigation of a possible role in the transcriptional regulation of adult beta-globin gene expression. J Cell Sci 1999;112:825-31. (Pubitemid 29179315)
18. Tripathi PK, Chatterjee SK. Elevated expression of ferritin H-chain mRNA in metastatic ovarian tumor. Cancer Invest 1996;14:518-26. (Pubitemid 26423514)
19. Weinstein RE, Bond BH, Silberberg BK. Tissue ferritin concentration in carcinoma of the breast. Cancer 1982;50:2406-9. (Pubitemid 13244177)
20. Bowles AP Jr, Pantazis CG, Wansley W. Use of verapamil to enhance the antiproliferative activity of BCNU in human glioma cells: an in vitro and in vivo study. J Neurosurg 1990;73:248-53. (Pubitemid 20238506)
21. Madhankumar AB, Slagle-Webb B, Mintz A, Sheehan JM, Connor JR. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. Mol Cancer Ther 2006;5:3162-9. (Pubitemid 46092059)
22. Roberts S, Bomford A. Ferritin iron kinetics and protein turnover in K562 cells. J Biol Chem 1988;263:19181-7. (Pubitemid 19016387)
23. Radisky DC, Kaplan J. Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. Biochem J 1998; 336:201-5. (Pubitemid 28532577)
24. Hernández-Yago J, Knecht E, Martínez-Ramón A, Grisolía S. Autophagy of ferritin incorporated into the cytosol of HeLa cells by liposomes. Cell Tissue Res 1980;205:303-9. (Pubitemid 10146830)
25. Madhankumar AB, Slagle-Webb B, Wang X, Yang QX, Antonetti DA, Miller PA, et al. Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model. Mol Cancer Ther 2009;8:648-54.
26. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther 1995;2:710-22. (Pubitemid 26043284)
27. Esposito C, Generosi J, Mossa G, Masotti A, Castellano AC. The analysis of serum effects on structure, size and toxicity of DDABDOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection efficiency. Colloids Surf B Biointerfaces 2006;53:187-92. (Pubitemid 44791895)
28. Wu YJ, Noguchi CT. Activation of globin gene expression by cDNAs from induced K562 cells. Evidence for involvement of ferritin in globin gene expression. J Biol Chem 1991;266: 17566-72. (Pubitemid 21907975)
29. Aung W, Hasegawa S, Furukawa T, Saga T. Potential role of ferritin heavy chain in oxidative stress and apoptosis in human mesothelial and mesothelioma cells: implications for asbestos-induced oncogenesis. Carcinogenesis 2007;28:2047-52. (Pubitemid 47500622)
30. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004;119:529-42. (Pubitemid 39482352)
31. Tang D, Lahti JM, Kidd VJ. Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis. J Biol Chem 2000;275:9303-7. (Pubitemid 30185152)
32. Zhang GP, Lu YY, Lv JC, Ou HJ. Effect of ursolic acid on caspase-3 and PARP expression of human MCF-7 cells. Zhongguo Zhong Yao Za Zhi 2006;31:141-4.
33. Gray CP, Franco AV, Arosio P, Hersey P. Immunosuppressive effects of melanoma-derived heavy-chain ferritin are dependent on stimulation of IL-10 production. Int J Cancer 2001;92:843-50. (Pubitemid 32467374)